Shujun Yang

Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial

Zixian Wang, Chengxu Cui, Jun Yao et al. · Cancer Cell · 2022 · 523 citations · Full text

Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)

Feng‐Hua Wang, Xiaoli Wei, Jifeng Feng et al. · Journal of Clinical Oncology · 2021 · 336 citations · Full text

Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial

Li Zhang, Shenglin Ma, Xiangqun Song et al. · The Lancet Oncology · 2012 · 225 citations

Medicine, Clinical Trials, Maintenance Therapy +9

Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology – Mainland China Subset Analysis of the PIONEER study

Yuankai Shi, Junling Li, Shucai Zhang et al. · PLoS ONE · 2015 · 200 citations · Full text

China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version)

Yuankai Shi, Yan Sun, Jinming Yu et al. · Asia-Pacific Journal of Clinical Oncology · 2016 · 44 citations

China Experts Consensus, Advanced Lung Disease, Medicine +7